Product Information

TERAZOSIN 2 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.1068 per EA under NDC 62135045990. Its NADAC has been published 184 times since May 10, 2023.

FDA first approved this application on Jan 30, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TERAZOSIN 2 MG CAPSULE

Terazosin
$0.1068per EA

Strength

2 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135045990

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TERAZOSIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075614

FDA Approved

1/30/2001

TE Code

AB

On Market Since

4/30/2021

Pharmacological Classes

Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker

Price Statistics

The NADAC for TERAZOSIN 2 MG CAPSULE has been published 184 times since May 10, 2023, and over the history we have for it it has declined 19.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1068 per EA
All-time high$0.1535 (Mar 13, 2024)
All-time low$0.1029 (Aug 19, 2026)
52-week high$0.1190
52-week low$0.1029
Median price$0.1338
Average price$0.1294
Largest weekly change-16.1% (Apr 17, 2024)
Weeks tracked184
Tracking sinceMay 10, 2023

Price History

1W

0.0%

1M

+1.2%

3M

-0.8%

6M

-1.7%

1Y

-11.4%

3Y

-26.3%

5Y

N/A

All

-19.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TERAZOSIN 2 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TERAZOSIN 2 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.1068 per EA (NDC 62135045990), effective Nov 11, 2026.

How has the price of TERAZOSIN 2 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TERAZOSIN 2 MG CAPSULE has declined 19.7%. It has been tracked across 184 weekly CMS publications since May 10, 2023.

What are the highest and lowest recorded NADAC prices for TERAZOSIN 2 MG CAPSULE?

Since May 10, 2023, the NADAC for TERAZOSIN 2 MG CAPSULE has ranged from a low of $0.1029 (Aug 19, 2026) to a high of $0.1535 (Mar 13, 2024), with a median of $0.1338 per EA.

Are there cheaper alternatives to TERAZOSIN 2 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TERAZOSIN 2 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TERAZOSIN 2 MG CAPSULE?

TERAZOSIN 2 MG CAPSULE (NDC 62135045990) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.